Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries I-Mab ADR (NQ: IMAB ) 1.060 +0.010 (+0.95%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 9, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about I-Mab ADR < Previous 1 2 3 4 5 6 Next > Why I-Mab Shares Are Jumping Today March 15, 2022 I-Mab (NASDAQ: IMAB) has provided updates on the recent development relating to the Holding Foreign Companies Accountable Act (HFCAA) and its implementation. I-Mab is not on this list, and it has... Via Benzinga 96 Biggest Movers From Yesterday March 15, 2022 Gainers Volt Information Sciences, Inc. (NYSE: VOLT) shares surged 94.7% to close at $5.88 on Monday after the company announced it would be acquired for $6 per share. Incannex... Via Benzinga Stocks That Hit 52-Week Lows On Friday March 11, 2022 During Friday's session, 198 companies made new 52-week lows. Key Facts About Today's 52-Week Highs And Lows: Alibaba Group Holding (NYSE:BABA) is the largest... Via Benzinga I-Mab Co-founds a SPAC: What's Up With That? March 01, 2022 Key Takeaways: Vivere Lifesciences Acquisition Corp., whose co-founders include U.S.-listed I-Mab, could become the first Hong Kong SPAC backed by a U.S.-listed Chinese company... Via Benzinga 50 Stocks Moving In Monday's Mid-Day Session March 14, 2022 Gainers Volt Information Sciences, Inc. (NYSE: VOLT) shares jumped 95.2% to $5.89 after the company announced it would be acquired for $6 per share. AgriFORCE Growing Systems,... Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session March 14, 2022 Gainers Erytech Pharma (NASDAQ:ERYP) stock rose 18.7% to $1.65 during Monday's pre-market session. The market value of their outstanding shares is at $51.1 million.... Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session March 10, 2022 Gainers Innate Pharma (NASDAQ:IPHA) stock increased by 13.7% to $3.32 during Thursday's pre-market session. The market value of their outstanding shares is at $264.6... Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session February 11, 2022 Gainers Dermata Therapeutics (NASDAQ:DRMA) shares moved upwards by 26.6% to $1.35 during Friday's regular session. As of 12:30 EST, Dermata Therapeutics's stock is... Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session February 10, 2022 Gainers Dermata Therapeutics (NASDAQ:DRMA) shares moved upwards by 26.1% to $1.35 during Thursday's regular session. The current volume of 17.5 million shares is 7266.... Via Benzinga Week In Review: Xbiome Acquires Diabetic Foot Ulcer Therapy In $139 Million Deal January 29, 2022 Xbiome, a Shenzhen AI-based microbiome drug development company, in-licensed China rights to an inflammatory disease therapy developed by Aurealis, a Swiss synthetic biology company, in a deal worth up... Via Talk Markets Connect Biopharma's Latest Dermatitis Drug Update Fails to Pump Up Shares January 13, 2022 Key takeaways: Loss-making Connect Biopharma says Phase 3 clinical trials of its CBP-201 drug for atopic dermatitis will begin in second half of this year Connect Biopharma... Via Benzinga New Energy Lands as Hottest Category Among Chinese Concept Stocks in 2021 – Bamboo Works Special Report January 26, 2022 Investors kept a close look at China’s solar and wind power stocks last year, but were least interested in the hobbled education sector By Bamboo Works team Chinese concept... Via Benzinga 46 Biggest Movers From Yesterday December 16, 2021 Gainers Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) gained 34.1% to settle at $12.58 on Wednesday. CMC Materials, Inc. (NASDAQ: CCMP) climbed 33.9% to close at $195.50 on... Via Benzinga 36 Stocks Moving In Wednesday's Mid-Day Session December 15, 2021 Gainers Nxt-ID, Inc. (NASDAQ: NXTD) shares gained 28.9% to $3.21 after the company said it was awarded U.S. General Services Administration contract to distribute personal... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session December 15, 2021 Gainers Gemini Therapeutics (NASDAQ:GMTX) shares moved upwards by 32.92% to $3.23 during Wednesday's pre-market session. The market value of their outstanding shares... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday December 15, 2021 We're at the halfway point of the week but there's no slowing down as we dive into the biggest pre-market stock movers for Wednesday! Via InvestorPlace Week In Review: Shanghai Regor To Discover Metabolic Therapies For Lilly In $1.55 Billion Deal December 11, 2021 Regor Therapeutics entered a $1.55 billion research pact with Eli & Lilly to discover therapies for metabolic disorders. Meanwhile, Beijing Avistone Pharma received a $200 million investment led by... Via Talk Markets 80 Biggest Movers From Yesterday November 17, 2021 Gainers BIMI International Medical Inc. (NASDAQ: BIMI) shares surged 55% to close at $1.00 on Tuesday as the company reported a narrower Q3 loss. Progenity, Inc. (NASDAQ: PROG)... Via Benzinga 53 Stocks Moving In Tuesday's Mid-Day Session November 16, 2021 Gainers BIMI International Medical Inc. (NASDAQ: BIMI) jumped 65.7% to $1.0691 as the company reported a narrower Q3 loss. Progenity, Inc. (NASDAQ: PROG) shares climbed 35.5% to... Via Benzinga Week In Review: Zai Lab Announces Two In-Licensings With Total Value Of $800 Million November 13, 2021 Shanghai Zai Lab announced two major in-licensings: a $615 million deal for two cancer drugs from Blueprint Medicines and a $187 million agreement for a psychiatric drug from Karuna Therapeutics. Via Talk Markets 12 Health Care Stocks Moving In Wednesday's Pre-Market Session November 10, 2021 Gainers Valneva (NASDAQ:VALN) shares increased by 24.51% to $50.34 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.6... Via Benzinga The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance November 10, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:... Via Benzinga Exposures COVID-19 I-Mab Shares Gain On Licensing Pact For Its Human Growth Hormone In China November 10, 2021 I-Mab (NASDAQ: IMAB) has collaborated with Jumpcan Pharmaceutical Group to develop, manufacture, and commercialize eftansomatropin alfa (TJ101) in mainland... Via Benzinga MorphoSys Presents Early Felzartamab Data From Autoimmune Kidney Disease Trial November 05, 2021 MorphoSys AG (NASDAQ: MOR) presented interim results from the M-PLACE Phase 1b/2a study with felzartamab at the 2021 Annual Meeting of the American Society of... Via Benzinga Week In Review: MicroTech Medical Staging $245 Million HK IPO For Diabetes Products October 10, 2021 MicroTech Medical, a Hangzhou company that offers diabetes monitoring and treatment devices, is conducting a Hong Kong IPO that would raise $254 million at the top of the price range. LianBio has filed... Via Talk Markets Topics Initial Public Offering Exposures Securities Market I-Mab In Talks With Pharma Giants About Partnership, Stake Sale: Bloomberg September 29, 2021 A year after I-Mab (NASDAQ: IMAB) made headlines with its $2.9 billion deal licensing a CD47 drug to AbbVie Inc (NYSE: ABBV), the biotech is reportedly... Via Benzinga Why Are I-Mab Shares Trading Higher On Tuesday? September 28, 2021 The Center for Drug Evaluation of China National Medical Products Administration has signed off I-Mab's (NASDAQ: IMAB) IND application to initiate a Phase 2... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session September 28, 2021 Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) shares increased by 70.28% to $9.11 during Tuesday's pre-market session. The company's market cap stands at $24.5... Via Benzinga I-Mab Stock Joins Rank Of Stocks With RS Ratings Over 90 September 20, 2021 Looking for the best stocks to buy? Focus on those with rising relative strength such as I-Mab stock, which saw a (RS) Rating upgrade to 93. Via Investor's Business Daily 48 Biggest Movers From Friday September 20, 2021 Gainers Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) shares jumped 135.4% to settle at $5.32 on Friday. The stock possibly traded higher following favorable data results by... Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.